On November 27, Grinvest reported that Haofan Biotech rose over 10%, Nuotai Bio and Chongqing Pharscin Pharmaceutical rose over 4%, while Jiangsu Hengrui Pharmaceuticals, Shenzhen Salubris Pharmaceuticals, and Xinjiang Bai Hua Cun Pharma Tech also increased.
A股减肥药板块普涨 昊帆生物涨超10%
The weight loss sector of A-shares is generally up, Haofan Biotechnology rose more than 10%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated